ADVERTISEMENT

Dietary Supplements

More Herbalife Distributors, More For Them To Do

More Herbalife Distributors, More For Them To Do

Direct seller's going to need more than larger number of distributors to generate sustainable growth, analysts say.

Bausch + Lomb Results Enhance Acquisition Image

Bausch + Lomb Results Enhance Acquisition Image

Firm’s future, as a separate business nearly 90% owned by Bausch Health, or as a standalone with different ownership or one not controlled by a majority owner, claims high profile in analysts’ comments and predictions. B+L is in the driver’s seat, they say.

US Nutrition Market Business News: Boka Well, Beachbody/HSAs, Dr Pepper/Ghost, More

US Nutrition Market Business News: Boka Well, Beachbody/HSAs, Dr Pepper/Ghost, More

Beachbody offers supplement sales using health savings accounts; PlantX, Boka launches oral health supplements; supplements take Form from RTE meal provider Factor; LIV3 JV behind marketing SugarShield; Ghost among Keurig Dr Pepper brands; and Nutra-Med Packaging expands with Legacy Pharma.

CRN Urges Tighter NDI Enforcement, Offers Its OWL As Model For FDA’s Potential Mandatory List

CRN Urges Tighter NDI Enforcement, Offers Its OWL As Model For FDA’s Potential Mandatory List

Trade group ready to work hand-in-hand with agency and other supplement industry stakeholders on potential regulatory changes or improvements, says president and CEO Steve Mister. “None of them are upsetting the basic balance of things that DSHEA was attempting to do, but there are things with 30 years that we've identified that need to be kind of fixed.”

Age-Restricting Sales Of Supplements, OTCs Remains Action Item For New Jersey Lawmakers

Age-Restricting Sales Of Supplements, OTCs Remains Action Item For New Jersey Lawmakers

New Jersey Assembly passed bill amended to expand extensively in defining which products, or ingredients, would be subject to a ban on sales to consumers younger than 18.

CRN Appeals To US Supplement Industry For ‘Promoting A More Responsible Industry’

CRN Appeals To US Supplement Industry For ‘Promoting A More Responsible Industry’

In first of two articles from recent interview, president and CEO Steve Mister discusses examples the trade group provides for self-regulation, “where people or companies who might not do it on their own because it would put them at a disadvantage if they were the only ones.”

In Emergency Rule, California Bans All THCs In Hemp Products: Industry Asks, Where’s The Fire?

In Emergency Rule, California Bans All THCs In Hemp Products: Industry Asks, Where’s The Fire?

California authorities say predominance of retailers licensed to sell hemp are compliant with ban published effective on 3 October through emergency regulation. But hemp industry’s contesting the regulation in state court, arguing state authorities inappropriately used emergency action to change state law on hemp products legislature passed in 2021.

US Q3 Consumer Health Earnings Preview: B+L’s Independence Has Private Equity Interest

US Q3 Consumer Health Earnings Preview: B+L’s Independence Has Private Equity Interest

Kenvue may have to start sharing time with Bausch + Lomb in investors’ discussions about the outlook for success at US consumer health firms separated from former parent firms as they and their competitors begin reporting the results for their latest quarters.

Consumer Health Market Business: ‘BBCOM,’ Hello Cake, Actylis/Pharm-Rx, 5 Star Franchises, More

Consumer Health Market Business: ‘BBCOM,’ Hello Cake, Actylis/Pharm-Rx, 5 Star Franchises, More

Bodybuilding.com reintroduces itself as ‘BBCOM’ with new plans; Flashlight Capital bids to buy Korea tobacco giant’s ginseng business; Hello Cake acquires Trigg Laboratories to be vertically integrated; Actylis expands into supplements, OTCs with Pharm-Rx; Helaina adds $45M funding, launches ingredient sales; ophthalmic drug firm Scope adds Eyevitamins supplements; 5 Star Nutrition’s franchising to expand.

Private Equity Poised To Take Control Of Opella But Sanofi Will Retain Sizable Stake

Private Equity Poised To Take Control Of Opella But Sanofi Will Retain Sizable Stake

Control of Sanofi Consumer Healthcare – recently rebranded as Opella – may soon pass to US private-equity firm CD&R but the French firm looks set to retain a substantial stake in a business which has some big Rx-to-OTC switches in the pipeline.